Oral Combination of Glimepiride/Vildagliptin/Metformin in Patients With T2D and Dual Treatment Failure
Clinical trial NCT04841096 · COMPLETED
Trial details
- NCT number
- NCT04841096
- Sponsor
- Laboratorios Silanes S.A. de C.V.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-21
- Primary completion
- 2024-03-15
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.